Last updated: July 2, 2018
Sponsor: Aier School of Ophthalmology, Central South University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Retina
Eye Disease
Treatment
N/AClinical Study ID
NCT03586193
SHIRB2018014
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients diagnosed as high myopic macular retinoschisis, with axial length more than 26.5mm.
Morphologic manifestation in OCT shows split between retinal layers in macular area.
Patients without severe systemic disease and can tolerate surgery.
Exclusion
Exclusion Criteria:
Patients also have other ocular disease, including glaucoma, keratitis,uveitis,retinal detachment,etc.
Patients with nystagmus or have difficult to open the eye.
Patients with severe systemic disease and cannot tolerate surgery.
Study Design
Total Participants: 40
Study Start date:
May 01, 2018
Estimated Completion Date:
May 31, 2019
Connect with a study center
Shanghai Aier Eye hospital
Shanghai, 200000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.